Published in Science on January 04, 2013
Functional roles of pulsing in genetic circuits. Science (2013) 1.84
A problem of persistence: still more questions than answers? Nat Rev Microbiol (2013) 1.68
Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob Agents Chemother (2013) 1.51
Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae. Nat Microbiol (2016) 1.46
The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells. Nat Rev Microbiol (2014) 1.46
Persisters, persistent infections and the Yin-Yang model. Emerg Microbes Infect (2014) 1.44
Dual-Reporter Mycobacteriophages (Φ2DRMs) Reveal Preexisting Mycobacterium tuberculosis Persistent Cells in Human Sputum. MBio (2016) 1.41
Phenotypic Diversity as a Mechanism to Exit Cellular Dormancy. Curr Biol (2015) 1.40
Deletion of a mycobacterial divisome factor collapses single-cell phenotypic heterogeneity. Nature (2017) 1.38
Microbial persistence and the road to drug resistance. Cell Host Microbe (2013) 1.37
Salmonella typhimurium intercepts Escherichia coli signaling to enhance antibiotic tolerance. Proc Natl Acad Sci U S A (2013) 1.29
Bacterial persister cell formation and dormancy. Appl Environ Microbiol (2013) 1.28
Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism. Nat Commun (2014) 1.17
Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol (2016) 1.12
A noisy linear map underlies oscillations in cell size and gene expression in bacteria. Nature (2015) 1.11
The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med (2016) 1.08
Subpolar addition of new cell wall is directed by DivIVA in mycobacteria. Proc Natl Acad Sci U S A (2014) 1.05
Mycobacterial mistranslation is necessary and sufficient for rifampicin phenotypic resistance. Proc Natl Acad Sci U S A (2014) 1.05
Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response. Virulence (2013) 1.04
Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis. J Infect Dis (2015) 0.99
Rapid cytolysis of Mycobacterium tuberculosis by faropenem, an orally bioavailable β-lactam antibiotic. Antimicrob Agents Chemother (2014) 0.99
c-di-GMP heterogeneity is generated by the chemotaxis machinery to regulate flagellar motility. Elife (2013) 0.95
Phenotypic heterogeneity is a selected trait in natural yeast populations subject to environmental stress. Environ Microbiol (2013) 0.93
Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model. ACS Chem Biol (2013) 0.92
TB drug development: immunology at the table. Immunol Rev (2015) 0.92
Noncanonical SMC protein in Mycobacterium smegmatis restricts maintenance of Mycobacterium fortuitum plasmids. Proc Natl Acad Sci U S A (2014) 0.90
Tunable stochastic pulsing in the Escherichia coli multiple antibiotic resistance network from interlinked positive and negative feedback loops. PLoS Comput Biol (2013) 0.89
Heterogeneous persister cells formation in Acinetobacter baumannii. PLoS One (2013) 0.88
Community behavior and spatial regulation within a bacterial microcolony in deep tissue sites serves to protect against host attack. Cell Host Microbe (2014) 0.88
Persisters-as elusive as ever. Appl Microbiol Biotechnol (2016) 0.87
BactImAS: a platform for processing and analysis of bacterial time-lapse microscopy movies. BMC Bioinformatics (2014) 0.87
Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens. Antimicrob Agents Chemother (2014) 0.87
Phenotypic heterogeneity in metabolic traits among single cells of a rare bacterial species in its natural environment quantified with a combination of flow cell sorting and NanoSIMS. Front Microbiol (2015) 0.87
The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis. ACS Infect Dis (2016) 0.86
Rapid in vivo detection of isoniazid-sensitive Mycobacterium tuberculosis by breath test. Nat Commun (2014) 0.86
Structure-activity relationships of 2-aminothiazoles effective against Mycobacterium tuberculosis. Bioorg Med Chem (2013) 0.86
Mycobacterium tuberculosis proteins involved in mycolic acid synthesis and transport localize dynamically to the old growing pole and septum. PLoS One (2014) 0.86
Pulsatile dynamics in the yeast proteome. Curr Biol (2014) 0.85
Persistence: a copacetic and parsimonious hypothesis for the existence of non-inherited resistance to antibiotics. Curr Opin Microbiol (2014) 0.85
Systems level mapping of metabolic complexity in Mycobacterium tuberculosis to identify high-value drug targets. J Transl Med (2014) 0.84
Design of a large-scale femtoliter droplet array for single-cell analysis of drug-tolerant and drug-resistant bacteria. Front Microbiol (2013) 0.84
Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence. Nat Microbiol (2016) 0.83
Illumination of growth, division and secretion by metabolic labeling of the bacterial cell surface. FEMS Microbiol Rev (2015) 0.83
RNA Futile Cycling in Model Persisters Derived from MazF Accumulation. MBio (2015) 0.83
New insights into TB physiology suggest untapped therapeutic opportunities. Immunol Rev (2015) 0.83
Noise-driven growth rate gain in clonal cellular populations. Proc Natl Acad Sci U S A (2016) 0.83
Mycobacterium tuberculosis Is Resistant to Isoniazid at a Slow Growth Rate by Single Nucleotide Polymorphisms in katG Codon Ser315. PLoS One (2015) 0.82
Staying in Shape: the Impact of Cell Shape on Bacterial Survival in Diverse Environments. Microbiol Mol Biol Rev (2016) 0.82
A developmental basis for stochasticity in floral organ numbers. Front Plant Sci (2014) 0.82
Chromosome organization and replisome dynamics in Mycobacterium smegmatis. MBio (2015) 0.81
Single-cell tracking reveals antibiotic-induced changes in mycobacterial energy metabolism. MBio (2015) 0.81
Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy. BMC Med (2016) 0.80
Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother (2015) 0.80
Stationary-Phase Persisters to Ofloxacin Sustain DNA Damage and Require Repair Systems Only during Recovery. MBio (2015) 0.80
Classic reaction kinetics can explain complex patterns of antibiotic action. Sci Transl Med (2015) 0.80
Stochastic expression of a multiple antibiotic resistance activator confers transient resistance in single cells. Sci Rep (2016) 0.80
Replication rates of Mycobacterium tuberculosis in human macrophages do not correlate with mycobacterial antibiotic susceptibility. PLoS One (2014) 0.80
Noise and low-level dynamics can coordinate multicomponent bet hedging mechanisms. Biophys J (2015) 0.80
Trans-species communication in the Mycobacterium tuberculosis-infected macrophage. Immunol Rev (2015) 0.80
New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria. Front Microbiol (2017) 0.79
Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor. EBioMedicine (2016) 0.79
Evolutionarily stable disequilibrium: endless dynamics of evolution in a stationary population. Proc Biol Sci (2016) 0.79
Confinement-Induced Drug-Tolerance in Mycobacteria Mediated by an Efflux Mechanism. PLoS One (2015) 0.79
Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology. F1000Res (2015) 0.79
Thioflavin T as a fluorescence probe for monitoring RNA metabolism at molecular and cellular levels. Nucleic Acids Res (2015) 0.79
Generation and filtering of gene expression noise by the bacterial cell cycle. BMC Biol (2016) 0.79
Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline. J Antimicrob Chemother (2016) 0.79
High Persister Mutants in Mycobacterium tuberculosis. PLoS One (2016) 0.78
Persistent Persister Misperceptions. Front Microbiol (2016) 0.78
Limits to compensatory adaptation and the persistence of antibiotic resistance in pathogenic bacteria. Evol Med Public Health (2014) 0.78
A High Throughput Screening Assay for Anti-Mycobacterial Small Molecules Based on Adenylate Kinase Release as a Reporter of Cell Lysis. PLoS One (2015) 0.78
Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds. PLoS One (2015) 0.78
Computational pharmacokinetics/pharmacodynamics of rifampin in a mouse tuberculosis infection model. J Pharmacokinet Pharmacodyn (2015) 0.78
Efficacy of Artilysin Art-175 against Resistant and Persistent Acinetobacter baumannii. Antimicrob Agents Chemother (2016) 0.78
Density-dependent adaptive resistance allows swimming bacteria to colonize an antibiotic gradient. ISME J (2015) 0.78
Slow-growing cells within isogenic populations have increased RNA polymerase error rates and DNA damage. Nat Commun (2015) 0.77
Structome analysis of virulent Mycobacterium tuberculosis, which survives with only 700 ribosomes per 0.1 fl of cytoplasm. PLoS One (2015) 0.77
Characterization of multi-drug tolerant persister cells in Streptococcus suis. BMC Microbiol (2014) 0.77
A rheostat mechanism governs the bifurcation of carbon flux in mycobacteria. Nat Commun (2016) 0.77
Interaction of Staphylococcus aureus persister cells with the host when in a persister state and following awakening. Sci Rep (2016) 0.77
Mechanical slowing-down of cytoplasmic diffusion allows in vivo counting of proteins in individual cells. Nat Commun (2016) 0.76
Analyzing Persister Physiology with Fluorescence-Activated Cell Sorting. Methods Mol Biol (2016) 0.76
Fe biomineralization mirrors individual metabolic activity in a nitrate-dependent Fe(II)-oxidizer. Front Microbiol (2015) 0.76
Development of Persister-FACSeq: a method to massively parallelize quantification of persister physiology and its heterogeneity. Sci Rep (2016) 0.76
Fumarate-Mediated Persistence of Escherichia coli against Antibiotics. Antimicrob Agents Chemother (2016) 0.76
Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis. J Med Chem (2016) 0.76
Persistent bacterial infections and persister cells. Nat Rev Microbiol (2017) 0.75
Elucidating population-wide mycobacterial replication dynamics at the single-cell level. Microbiology (2016) 0.75
Diverse drug-resistant subpopulations of Mycobacterium tuberculosis are sustained in continuous culture. J R Soc Interface (2016) 0.75
Virulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpC. PLoS One (2016) 0.75
Contribution of high-content imaging technologies to the development of anti-infective drugs. Cytometry A (2016) 0.75
Determining the Limitations and Benefits of Noise in Gene Regulation and Signal Transduction through Single Cell, Microscopy-Based Analysis. J Mol Biol (2017) 0.75
The mevalonate auxotrophic mutant of Staphylococcus aureus can adapt to mevalonate depletion. Antimicrob Agents Chemother (2013) 0.75
Mycobacterial Growth. Cold Spring Harb Perspect Med (2015) 0.75
Antimicrobial resistance: Survival by reversible resistance. Nat Microbiol (2016) 0.75
De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells formed against Antituberculosis Drugs In Vitro. Antimicrob Agents Chemother (2016) 0.75
Bacterial physiology: no rest for the persisters. Nat Rev Microbiol (2013) 0.75
Next-generation antimicrobials: from chemical biology to first-in-class drugs. Arch Pharm Res (2015) 0.75
Phenotypic Modifications in Staphylococcus aureus Cells Exposed to High Concentrations of Vancomycin and Teicoplanin. Front Microbiol (2016) 0.75
Mathematical modeling of dormant cell formation in growing biofilm. Front Microbiol (2015) 0.75
Bacterial persistence as a phenotypic switch. Science (2004) 15.80
Phenotypic diversity, population growth, and information in fluctuating environments. Science (2005) 8.21
Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med (2005) 6.10
Combinatorial synthesis of genetic networks. Science (2002) 5.91
Establishment of developmental precision and proportions in the early Drosophila embryo. Nature (2002) 5.55
Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science (2003) 5.50
M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) (2004) 4.38
Resilient circadian oscillator revealed in individual cyanobacteria. Nature (2004) 3.84
Mechanisms of noise-resistance in genetic oscillators. Proc Natl Acad Sci U S A (2002) 3.78
Protein sectors: evolutionary units of three-dimensional structure. Cell (2009) 3.76
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. Science (2009) 3.39
Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients. Proc Natl Acad Sci U S A (2003) 3.14
Bacterial persistence: a model of survival in changing environments. Genetics (2005) 2.97
Simpson's paradox in a synthetic microbial system. Science (2009) 2.97
Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet (2011) 2.86
Replication dynamics of Mycobacterium tuberculosis in chronically infected mice. Infect Immun (2005) 2.74
Microbial phenotypic heterogeneity and antibiotic tolerance. Curr Opin Microbiol (2007) 2.70
Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence. Mol Microbiol (2006) 2.39
Nonoptimal microbial response to antibiotics underlies suppressive drug interactions. Cell (2009) 2.27
DNA looping and physical constraints on transcription regulation. J Mol Biol (2003) 2.26
Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol Microbiol (2004) 2.26
Carbon metabolism of intracellular bacteria. Cell Microbiol (2006) 2.17
Modeling network dynamics: the lac operon, a case study. J Cell Biol (2003) 2.03
Drug interactions modulate the potential for evolution of resistance. Proc Natl Acad Sci U S A (2008) 1.98
Functional characterization of a vitamin B12-dependent methylmalonyl pathway in Mycobacterium tuberculosis: implications for propionate metabolism during growth on fatty acids. J Bacteriol (2008) 1.82
Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations. Chem Biol (2012) 1.79
Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis. Sci Transl Med (2012) 1.78
Environmental stresses can alleviate the average deleterious effect of mutations. J Biol (2003) 1.76
A problem of persistence: still more questions than answers? Nat Rev Microbiol (2013) 1.68
Disruption of mptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs. Mol Microbiol (2003) 1.62
Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis. Mol Microbiol (2006) 1.61
Role of the methylcitrate cycle in propionate metabolism and detoxification in Mycobacterium smegmatis. Microbiology (2007) 1.50
Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother (2010) 1.43
An interdomain sector mediating allostery in Hsp70 molecular chaperones. Mol Syst Biol (2010) 1.42
Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis. Antimicrob Agents Chemother (2012) 1.31
Optimal drug synergy in antimicrobial treatments. PLoS Comput Biol (2010) 1.23
Contingency and statistical laws in replicate microbial closed ecosystems. Cell (2012) 1.23
Ribonucleotide reduction in Mycobacterium tuberculosis: function and expression of genes encoding class Ib and class II ribonucleotide reductases. Infect Immun (2003) 1.23
Cooperation and Hamilton's rule in a simple synthetic microbial system. Mol Syst Biol (2010) 1.22
Single-cell dynamics of the chromosome replication and cell division cycles in mycobacteria. Nat Commun (2013) 1.21
Neuronal couplings between retinal ganglion cells inferred by efficient inverse statistical physics methods. Proc Natl Acad Sci U S A (2009) 1.20
Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice. Proc Natl Acad Sci U S A (2010) 1.13
Development of a repressible mycobacterial promoter system based on two transcriptional repressors. Nucleic Acids Res (2010) 1.13
Quantitation of cellular dynamics in growing Arabidopsis roots with light sheet microscopy. PLoS One (2011) 1.10
Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung. PLoS One (2008) 1.09
Spontaneous phthiocerol dimycocerosate-deficient variants of Mycobacterium tuberculosis are susceptible to gamma interferon-mediated immunity. Infect Immun (2011) 1.05
Cooperative DNA and histone binding by Uhrf2 links the two major repressive epigenetic pathways. J Cell Biochem (2011) 1.05
Life on the inside for Mycobacterium tuberculosis. Nat Med (2003) 1.04
H2A.Z.2.2 is an alternatively spliced histone H2A.Z variant that causes severe nucleosome destabilization. Nucleic Acids Res (2012) 1.03
Infection of mice with aerosolized Mycobacterium tuberculosis: use of a nose-only apparatus for delivery of low doses of inocula and design of an ultrasafe facility. Appl Environ Microbiol (2002) 1.03
Building a morbidostat: an automated continuous-culture device for studying bacterial drug resistance under dynamically sustained drug inhibition. Nat Protoc (2013) 1.02
Contrasting persistence strategies in Salmonella and Mycobacterium. Curr Opin Microbiol (2010) 1.00
Identification of Mycobacterium tuberculosis counterimmune (cim) mutants in immunodeficient mice by differential screening. Infect Immun (2004) 0.99
Targeting and tracing of specific DNA sequences with dTALEs in living cells. Nucleic Acids Res (2013) 0.99
EspD is critical for the virulence-mediating ESX-1 secretion system in Mycobacterium tuberculosis. J Bacteriol (2011) 0.99
Fine tuning by human CD1e of lipid-specific immune responses. Proc Natl Acad Sci U S A (2011) 0.98
Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. Vaccine (2011) 0.98
Speed, dissipation, and error in kinetic proofreading. Proc Natl Acad Sci U S A (2012) 0.97
Printing multistrain bacterial patterns with a piezoelectric inkjet printer. PLoS One (2007) 0.95
A single-cell perspective on non-growing but metabolically active (NGMA) bacteria. Curr Top Microbiol Immunol (2013) 0.95
Assessing the essentiality of the decaprenyl-phospho-d-arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants. Mol Microbiol (2014) 0.94
Mycobacterium tuberculosis requires phosphate-responsive gene regulation to resist host immunity. Infect Immun (2012) 0.93
Lopinavir/ritonavir plus saquinavir in salvage therapy; pharmacokinetics, tolerability and efficacy. AIDS (2003) 0.93
Mycobacterium tuberculosis EspB binds phospholipids and mediates EsxA-independent virulence. Mol Microbiol (2013) 0.92
Microbial population dynamics by digital in-line holographic microscopy. Rev Sci Instrum (2010) 0.91
A vitamin B₁₂ transporter in Mycobacterium tuberculosis. Open Biol (2013) 0.88
Phenotypic profiling of Mycobacterium tuberculosis EspA point mutants reveals that blockage of ESAT-6 and CFP-10 secretion in vitro does not always correlate with attenuation of virulence. J Bacteriol (2013) 0.87
Behavioral diversity in microbes and low-dimensional phenotypic spaces. Proc Natl Acad Sci U S A (2013) 0.86
Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis. Vaccine (2005) 0.86
Cutting edge: a naturally occurring mutation in CD1e impairs lipid antigen presentation. J Immunol (2008) 0.85
M. tuberculosis Rv2252 encodes a diacylglycerol kinase involved in the biosynthesis of phosphatidylinositol mannosides (PIMs). Mol Microbiol (2006) 0.84
Malachite green interferes with postantibiotic recovery of mycobacteria. Antimicrob Agents Chemother (2012) 0.84
Dielectrophoresis-based purification of antibiotic-treated bacterial subpopulations. Lab Chip (2014) 0.83
Polymer-population mapping and localization in the space of phenotypes. Phys Rev Lett (2006) 0.82
Structure, function and dynamics of nuclear subcompartments. Curr Opin Cell Biol (2012) 0.82
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity. J Med Chem (2014) 0.82
A multidrug-resistant, acr1-deficient clinical isolate of Mycobacterium tuberculosis is unimpaired for replication in macrophages. J Infect Dis (2006) 0.81
NSAID-derived γ-secretase modulation requires an acidic moiety on the carbazole scaffold. Bioorg Med Chem (2011) 0.80
Functional characterization of histamine receptor subtypes in a human bronchial epithelial cell line. Int J Mol Med (2006) 0.80
Expression of the leptin receptor outside of bone marrow-derived cells regulates tuberculosis control and lung macrophage MHC expression. J Immunol (2011) 0.79
Administration of indinavir and low-dose ritonavir (800/100 mg twice daily) with food reduces nephrotoxic peak plasma levels of indinavir. Antivir Ther (2003) 0.79
Increased flexibility and liposome-binding capacity of CD1e at endosomal pH. FEBS J (2011) 0.78
Lysosomal-associated transmembrane protein 5 (LAPTM5) is a molecular partner of CD1e. PLoS One (2012) 0.75
DNMT1 mutations found in HSANIE patients affect interaction with UHRF1 and neuronal differentiation. Hum Mol Genet (2017) 0.75
Bayesian mixed-effects model for the analysis of a series of FRAP images. Stat Appl Genet Mol Biol (2015) 0.75
Comparison of two reduced-dose regimens of indinavir (600 mg vs 400 mg twice daily) and ritonavir (100 mg twice daily) in healthy volunteers (COREDIR). Antivir Ther (2004) 0.75
Recent advances in tuberculosis research in India. Adv Biochem Eng Biotechnol (2003) 0.75
Circulating epithelial tumor cells as a prognostic tool for malignant melanoma. Melanoma Res (2017) 0.75